We have complementary backgrounds as well as a positive, long-standing working-relationship, which will be highly conducive to solving complex problems for our clients.
WEST LAFAYETTE, Ind. (PRWEB) July 20, 2020
Improved Pharma is pleased to announce new collaborations with Westport Pharmaceutical Consulting, LLC (dba WPC, LLC) and Ravine Pharmaceuticals LLC enabling expansion of expertise and service offerings to the pharmaceutical industry in support of drug substance and drug product development.
These additions bring a vast amount of relevant industrial and service experience to the Improved Pharma team. Dr. Brett Cowans brings thirty years of experience as a solid-state analytical chemist including over twenty years serving the pharmaceutical industry as an expert in the solid forms of small molecules, i.e. polymorphs, salts and cocrystals. Dr. Susan Bogdanowich-Knipp lauds over twenty-five years in both the large pharma industry and contract research organization with broad experience ranging from pre-formulation through Phase II development for both small and large molecules. Together with Improved Pharma, the capacity for polymorph screening, salt screening, pre-formulation studies, analytical research, and problem solving expands greatly.
“At Improved Pharma, we are all about helping our clients bring their drugs to market faster,” notes Dr. Pamela Smith, COO of Improved Pharma. “We do that by bringing together experts in the field who have earned a strong reputation as service-oriented scientists. We also are constantly advancing the field of pharmaceutical development with research studies that we then pass along to our clients. This expansion comes at the perfect time, as our business is growing rapidly.”
“I am thrilled to be working again with Dr. Stephen Byrn, as well as Drs. Smith and Cowans,” states Dr. Bogdanowich-Knipp, President and Consultant of Ravine Pharmaceuticals LLC. “We have complementary backgrounds as well as a positive, long-standing working-relationship, which will be highly conducive to solving complex problems for our clients.”
“Together, we have a long history of providing innovative solutions to complex solid-state problems,” adds Dr. Cowans, President of WPC, LLC.
Both Ravine Pharmaceuticals LLC and WPC, LLC will have the unique advantage of sharing laboratory facilities with Improved Pharma. For more information, please contact Improved Pharma.
About Improved Pharma
Improved Pharma is a research and information company dedicated to improving pharmaceutical methods, formulations, and processes. Services include solid-state form studies, formulation design, synchrotron techniques, analytical testing, and expert consulting for the development and defense of intellectual property matters. The company was founded in 2006 by Stephen and Sarah Byrn, who also founded SSCI.